

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of fibrinolysis (GO:0051918) | 6.70706480 |
| 2 | complement activation, classical pathway (GO:0006958) | 6.59872057 |
| 3 | regulation of fibrinolysis (GO:0051917) | 6.42697077 |
| 4 | drug catabolic process (GO:0042737) | 6.27658583 |
| 5 | exogenous drug catabolic process (GO:0042738) | 6.22533909 |
| 6 | urea metabolic process (GO:0019627) | 5.72812383 |
| 7 | complement activation (GO:0006956) | 5.71575547 |
| 8 | regulation of protein activation cascade (GO:2000257) | 5.71192727 |
| 9 | glyoxylate metabolic process (GO:0046487) | 5.60989727 |
| 10 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.55408905 |
| 11 | protein carboxylation (GO:0018214) | 5.55408905 |
| 12 | fibrinolysis (GO:0042730) | 5.55365606 |
| 13 | negative regulation of sterol transport (GO:0032372) | 5.53802604 |
| 14 | negative regulation of cholesterol transport (GO:0032375) | 5.53802604 |
| 15 | complement activation, alternative pathway (GO:0006957) | 5.49430330 |
| 16 | regulation of complement activation (GO:0030449) | 5.48248745 |
| 17 | protein activation cascade (GO:0072376) | 5.42217633 |
| 18 | nitrogen cycle metabolic process (GO:0071941) | 5.26089644 |
| 19 | L-phenylalanine catabolic process (GO:0006559) | 5.25975749 |
| 20 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.25975749 |
| 21 | urea cycle (GO:0000050) | 5.25729078 |
| 22 | phospholipid efflux (GO:0033700) | 5.19552495 |
| 23 | epoxygenase P450 pathway (GO:0019373) | 5.15150027 |
| 24 | cellular glucuronidation (GO:0052695) | 5.10481844 |
| 25 | L-phenylalanine metabolic process (GO:0006558) | 4.96682085 |
| 26 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.96682085 |
| 27 | uronic acid metabolic process (GO:0006063) | 4.92778095 |
| 28 | glucuronate metabolic process (GO:0019585) | 4.92778095 |
| 29 | ethanol oxidation (GO:0006069) | 4.83534315 |
| 30 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.73549369 |
| 31 | regulation of cholesterol esterification (GO:0010872) | 4.71412857 |
| 32 | drug metabolic process (GO:0017144) | 4.45541619 |
| 33 | protein-lipid complex remodeling (GO:0034368) | 4.42836430 |
| 34 | macromolecular complex remodeling (GO:0034367) | 4.42836430 |
| 35 | plasma lipoprotein particle remodeling (GO:0034369) | 4.42836430 |
| 36 | phenylpropanoid metabolic process (GO:0009698) | 4.36794976 |
| 37 | regulation of triglyceride catabolic process (GO:0010896) | 4.35698306 |
| 38 | blood coagulation, intrinsic pathway (GO:0007597) | 4.32692856 |
| 39 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.30204623 |
| 40 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.29653716 |
| 41 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.29653716 |
| 42 | regulation of apoptotic cell clearance (GO:2000425) | 4.28648055 |
| 43 | negative regulation of blood coagulation (GO:0030195) | 4.28629186 |
| 44 | negative regulation of hemostasis (GO:1900047) | 4.28629186 |
| 45 | regulation of plasminogen activation (GO:0010755) | 4.26425305 |
| 46 | high-density lipoprotein particle remodeling (GO:0034375) | 4.16392957 |
| 47 | acute-phase response (GO:0006953) | 3.95359649 |
| 48 | negative regulation of coagulation (GO:0050819) | 3.94765196 |
| 49 | alkaloid metabolic process (GO:0009820) | 3.91703051 |
| 50 | positive regulation of blood coagulation (GO:0030194) | 3.91180525 |
| 51 | positive regulation of hemostasis (GO:1900048) | 3.91180525 |
| 52 | aromatic amino acid family catabolic process (GO:0009074) | 3.90164234 |
| 53 | omega-hydroxylase P450 pathway (GO:0097267) | 3.88157190 |
| 54 | ethanol metabolic process (GO:0006067) | 3.83830848 |
| 55 | hormone catabolic process (GO:0042447) | 3.82224120 |
| 56 | plasma lipoprotein particle assembly (GO:0034377) | 3.81633858 |
| 57 | low-density lipoprotein particle remodeling (GO:0034374) | 3.80846936 |
| 58 | negative regulation of wound healing (GO:0061045) | 3.78915382 |
| 59 | bile acid metabolic process (GO:0008206) | 3.77161149 |
| 60 | regulation of humoral immune response (GO:0002920) | 3.74850719 |
| 61 | cholesterol efflux (GO:0033344) | 3.72519922 |
| 62 | arginine metabolic process (GO:0006525) | 3.70430073 |
| 63 | positive regulation of respiratory burst (GO:0060267) | 3.68974141 |
| 64 | positive regulation of coagulation (GO:0050820) | 3.65033766 |
| 65 | bile acid and bile salt transport (GO:0015721) | 3.65005450 |
| 66 | acylglycerol homeostasis (GO:0055090) | 3.61510385 |
| 67 | triglyceride homeostasis (GO:0070328) | 3.61510385 |
| 68 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.60841078 |
| 69 | serine family amino acid catabolic process (GO:0009071) | 3.58001547 |
| 70 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.55740763 |
| 71 | oxidative demethylation (GO:0070989) | 3.53934958 |
| 72 | negative regulation of lipase activity (GO:0060192) | 3.53105841 |
| 73 | primary alcohol catabolic process (GO:0034310) | 3.52965463 |
| 74 | bile acid biosynthetic process (GO:0006699) | 3.49233342 |
| 75 | plasma lipoprotein particle organization (GO:0071827) | 3.49184434 |
| 76 | protein-lipid complex assembly (GO:0065005) | 3.46220377 |
| 77 | lipoprotein metabolic process (GO:0042157) | 3.45498119 |
| 78 | polyketide metabolic process (GO:0030638) | 3.44856618 |
| 79 | doxorubicin metabolic process (GO:0044598) | 3.44856618 |
| 80 | daunorubicin metabolic process (GO:0044597) | 3.44856618 |
| 81 | reverse cholesterol transport (GO:0043691) | 3.43699530 |
| 82 | arginine catabolic process (GO:0006527) | 3.43083095 |
| 83 | flavonoid metabolic process (GO:0009812) | 3.38311583 |
| 84 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.37628542 |
| 85 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.35332697 |
| 86 | protein-lipid complex subunit organization (GO:0071825) | 3.31834622 |
| 87 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.24847087 |
| 88 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.23342340 |
| 89 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.20495058 |
| 90 | intestinal absorption (GO:0050892) | 3.18244323 |
| 91 | negative regulation of lipid transport (GO:0032369) | 3.16836328 |
| 92 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.15932277 |
| 93 | intestinal cholesterol absorption (GO:0030299) | 3.14070931 |
| 94 | plasma lipoprotein particle clearance (GO:0034381) | 3.12223491 |
| 95 | acute inflammatory response (GO:0002526) | 3.11704945 |
| 96 | S-adenosylmethionine metabolic process (GO:0046500) | 3.03169233 |
| 97 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.02280881 |
| 98 | regulation of lipoprotein particle clearance (GO:0010984) | 2.99314489 |
| 99 | amino-acid betaine metabolic process (GO:0006577) | 2.97034361 |
| 100 | negative regulation of protein activation cascade (GO:2000258) | 2.96508919 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.03561041 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.57830560 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.38330435 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.15730152 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.00133792 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.99021864 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.59553852 |
| 8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.51108654 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.33649295 |
| 10 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.71194698 |
| 11 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.68441312 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.51135479 |
| 13 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.46114166 |
| 14 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.27292546 |
| 15 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.27200829 |
| 16 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.12740778 |
| 17 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.09892065 |
| 18 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.89558905 |
| 19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.83658914 |
| 20 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.81876492 |
| 21 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.77846495 |
| 22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.68570979 |
| 23 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.66635491 |
| 24 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.59196960 |
| 25 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.54810404 |
| 26 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.53379320 |
| 27 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.52170067 |
| 28 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.47912091 |
| 29 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.41353528 |
| 30 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.40134789 |
| 31 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.38876142 |
| 32 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.38632675 |
| 33 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.35399657 |
| 34 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.30250599 |
| 35 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.29267608 |
| 36 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.26161092 |
| 37 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.25514357 |
| 38 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.19712379 |
| 39 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.19605195 |
| 40 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.17430687 |
| 41 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.17126786 |
| 42 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.17000555 |
| 43 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.16950604 |
| 44 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.16434959 |
| 45 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.16131113 |
| 46 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.15291960 |
| 47 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.15198226 |
| 48 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.15113025 |
| 49 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.12153081 |
| 50 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.09034732 |
| 51 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.08885467 |
| 52 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07967094 |
| 53 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.07282175 |
| 54 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06878847 |
| 55 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.05932221 |
| 56 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.05867016 |
| 57 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.04930763 |
| 58 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.04640726 |
| 59 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.02886665 |
| 60 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02047296 |
| 61 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00353214 |
| 62 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.99804320 |
| 63 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.98632124 |
| 64 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98369283 |
| 65 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.97653186 |
| 66 | SA1_27219007_Chip-Seq_Bcells_Human | 0.96538784 |
| 67 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.96451105 |
| 68 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.95514961 |
| 69 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95047321 |
| 70 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.93965727 |
| 71 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.93421483 |
| 72 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.92195980 |
| 73 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.91225525 |
| 74 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.91189779 |
| 75 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.90544288 |
| 76 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.89277439 |
| 77 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.87527667 |
| 78 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.87392288 |
| 79 | P68_20966046_ChIP-Seq_HELA_Human | 0.87229982 |
| 80 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.87005085 |
| 81 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.86126077 |
| 82 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.82933939 |
| 83 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.82174757 |
| 84 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.82058731 |
| 85 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.81666607 |
| 86 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.81569497 |
| 87 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.80754144 |
| 88 | GATA1_19941826_ChIP-Seq_K562_Human | 0.80230799 |
| 89 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80205430 |
| 90 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.79371820 |
| 91 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.78843167 |
| 92 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.78770905 |
| 93 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.78247430 |
| 94 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.78043451 |
| 95 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.77662425 |
| 96 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.77235053 |
| 97 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.77061903 |
| 98 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.76712831 |
| 99 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.76317272 |
| 100 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.76062974 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.02857824 |
| 2 | MP0005360_urolithiasis | 5.75517654 |
| 3 | MP0002138_abnormal_hepatobiliary_system | 4.65805141 |
| 4 | MP0005365_abnormal_bile_salt | 4.54050241 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 4.24839527 |
| 6 | MP0003195_calcinosis | 3.70920660 |
| 7 | MP0009840_abnormal_foam_cell | 3.68259872 |
| 8 | MP0001666_abnormal_nutrient_absorption | 3.18609177 |
| 9 | MP0008875_abnormal_xenobiotic_pharmacok | 2.81567989 |
| 10 | MP0003252_abnormal_bile_duct | 2.46341547 |
| 11 | MP0003868_abnormal_feces_composition | 2.37690862 |
| 12 | MP0000685_abnormal_immune_system | 2.32023488 |
| 13 | MP0010329_abnormal_lipoprotein_level | 2.15604213 |
| 14 | MP0005451_abnormal_body_composition | 2.08120822 |
| 15 | MP0003806_abnormal_nucleotide_metabolis | 1.98784608 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 1.93930932 |
| 17 | MP0002254_reproductive_system_inflammat | 1.81509287 |
| 18 | MP0010155_abnormal_intestine_physiology | 1.78835045 |
| 19 | MP0005332_abnormal_amino_acid | 1.77946238 |
| 20 | MP0004510_myositis | 1.77848587 |
| 21 | MP0003724_increased_susceptibility_to | 1.71186861 |
| 22 | MP0002876_abnormal_thyroid_physiology | 1.68835315 |
| 23 | MP0000604_amyloidosis | 1.66013866 |
| 24 | MP0003436_decreased_susceptibility_to | 1.62834846 |
| 25 | MP0009785_altered_susceptibility_to | 1.62098739 |
| 26 | MP0001873_stomach_inflammation | 1.60744076 |
| 27 | MP0000609_abnormal_liver_physiology | 1.53969304 |
| 28 | MP0001790_abnormal_immune_system | 1.50061583 |
| 29 | MP0005387_immune_system_phenotype | 1.50061583 |
| 30 | MP0001835_abnormal_antigen_presentation | 1.47859440 |
| 31 | MP0004019_abnormal_vitamin_homeostasis | 1.41383612 |
| 32 | MP0005025_abnormal_response_to | 1.38852625 |
| 33 | MP0005058_abnormal_lysosome_morphology | 1.34658329 |
| 34 | MP0004858_abnormal_nervous_system | 1.29826391 |
| 35 | MP0005166_decreased_susceptibility_to | 1.29581708 |
| 36 | MP0001764_abnormal_homeostasis | 1.26766441 |
| 37 | MP0002118_abnormal_lipid_homeostasis | 1.23278370 |
| 38 | MP0008469_abnormal_protein_level | 1.22721908 |
| 39 | MP0010234_abnormal_vibrissa_follicle | 1.20959990 |
| 40 | MP0005319_abnormal_enzyme/_coenzyme | 1.18762140 |
| 41 | MP0003303_peritoneal_inflammation | 1.17435162 |
| 42 | MP0009643_abnormal_urine_homeostasis | 1.17262938 |
| 43 | MP0003300_gastrointestinal_ulcer | 1.17062254 |
| 44 | MP0005671_abnormal_response_to | 1.14414390 |
| 45 | MP0000566_synostosis | 1.13384661 |
| 46 | MP0003329_amyloid_beta_deposits | 1.06517759 |
| 47 | MP0001800_abnormal_humoral_immune | 1.05761126 |
| 48 | MP0004782_abnormal_surfactant_physiolog | 1.04845915 |
| 49 | MP0004947_skin_inflammation | 1.04267615 |
| 50 | MP0000858_altered_metastatic_potential | 1.01692833 |
| 51 | MP0003075_altered_response_to | 1.00561441 |
| 52 | MP0001845_abnormal_inflammatory_respons | 0.99547702 |
| 53 | MP0001533_abnormal_skeleton_physiology | 0.96784757 |
| 54 | MP0005023_abnormal_wound_healing | 0.95210101 |
| 55 | MP0003866_abnormal_defecation | 0.94503220 |
| 56 | MP0002148_abnormal_hypersensitivity_rea | 0.93741314 |
| 57 | MP0003183_abnormal_peptide_metabolism | 0.93296567 |
| 58 | MP0010368_abnormal_lymphatic_system | 0.93202244 |
| 59 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.92794711 |
| 60 | MP0006082_CNS_inflammation | 0.90601929 |
| 61 | MP0009333_abnormal_splenocyte_physiolog | 0.90127803 |
| 62 | MP0004264_abnormal_extraembryonic_tissu | 0.87704056 |
| 63 | MP0002419_abnormal_innate_immunity | 0.87212478 |
| 64 | MP0003453_abnormal_keratinocyte_physiol | 0.82269784 |
| 65 | MP0001663_abnormal_digestive_system | 0.81584510 |
| 66 | MP0009764_decreased_sensitivity_to | 0.80977644 |
| 67 | MP0005000_abnormal_immune_tolerance | 0.80926519 |
| 68 | MP0003879_abnormal_hair_cell | 0.79783300 |
| 69 | MP0009763_increased_sensitivity_to | 0.78988681 |
| 70 | MP0002277_abnormal_respiratory_mucosa | 0.76908306 |
| 71 | MP0002136_abnormal_kidney_physiology | 0.75904950 |
| 72 | MP0005464_abnormal_platelet_physiology | 0.75679087 |
| 73 | MP0000249_abnormal_blood_vessel | 0.75335439 |
| 74 | MP0000598_abnormal_liver_morphology | 0.73484365 |
| 75 | MP0010352_gastrointestinal_tract_polyps | 0.73193432 |
| 76 | MP0009642_abnormal_blood_homeostasis | 0.71721410 |
| 77 | MP0003638_abnormal_response/metabolism_ | 0.71639393 |
| 78 | MP0002452_abnormal_antigen_presenting | 0.71124325 |
| 79 | MP0003705_abnormal_hypodermis_morpholog | 0.70584113 |
| 80 | MP0002796_impaired_skin_barrier | 0.70461440 |
| 81 | MP0002971_abnormal_brown_adipose | 0.69411571 |
| 82 | MP0009697_abnormal_copulation | 0.68692845 |
| 83 | MP0002723_abnormal_immune_serum | 0.68601585 |
| 84 | MP0005409_darkened_coat_color | 0.67129241 |
| 85 | MP0000465_gastrointestinal_hemorrhage | 0.65233734 |
| 86 | MP0002168_other_aberrant_phenotype | 0.64329118 |
| 87 | MP0003763_abnormal_thymus_physiology | 0.61836161 |
| 88 | MP0005381_digestive/alimentary_phenotyp | 0.61068847 |
| 89 | MP0005636_abnormal_mineral_homeostasis | 0.60934514 |
| 90 | MP0005164_abnormal_response_to | 0.58650851 |
| 91 | MP0003566_abnormal_cell_adhesion | 0.58543905 |
| 92 | MP0002098_abnormal_vibrissa_morphology | 0.58228085 |
| 93 | MP0002166_altered_tumor_susceptibility | 0.57960231 |
| 94 | MP0000477_abnormal_intestine_morphology | 0.54944949 |
| 95 | MP0005376_homeostasis/metabolism_phenot | 0.54624141 |
| 96 | MP0005670_abnormal_white_adipose | 0.54175255 |
| 97 | MP0008874_decreased_physiological_sensi | 0.53366762 |
| 98 | MP0001851_eye_inflammation | 0.53209224 |
| 99 | MP0000678_abnormal_parathyroid_gland | 0.52667232 |
| 100 | MP0002132_abnormal_respiratory_system | 0.52044449 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 8.37386488 |
| 2 | Systemic lupus erythematosus (HP:0002725) | 7.85388909 |
| 3 | Deep venous thrombosis (HP:0002625) | 7.42488667 |
| 4 | Complement deficiency (HP:0004431) | 7.24748569 |
| 5 | Abnormality of complement system (HP:0005339) | 6.40677907 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.28579777 |
| 7 | Glomerulonephritis (HP:0000099) | 6.01832811 |
| 8 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.65943594 |
| 9 | Prolonged partial thromboplastin time (HP:0003645) | 5.62221626 |
| 10 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.41399945 |
| 11 | Joint hemorrhage (HP:0005261) | 5.28529816 |
| 12 | Nephritis (HP:0000123) | 4.58910618 |
| 13 | Xanthomatosis (HP:0000991) | 4.46127056 |
| 14 | Malnutrition (HP:0004395) | 4.34568174 |
| 15 | Hyperlipoproteinemia (HP:0010980) | 4.16303843 |
| 16 | Hemorrhage of the eye (HP:0011885) | 3.88457726 |
| 17 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.77298295 |
| 18 | Abnormality of proline metabolism (HP:0010907) | 3.59598229 |
| 19 | Hydroxyprolinuria (HP:0003080) | 3.59598229 |
| 20 | Conjugated hyperbilirubinemia (HP:0002908) | 3.57740148 |
| 21 | Intrahepatic cholestasis (HP:0001406) | 3.51344268 |
| 22 | Hypolipoproteinemia (HP:0010981) | 3.46646611 |
| 23 | Fat malabsorption (HP:0002630) | 3.38765015 |
| 24 | Purpura (HP:0000979) | 3.13717451 |
| 25 | Menorrhagia (HP:0000132) | 2.96985606 |
| 26 | Abnormality of the common coagulation pathway (HP:0010990) | 2.86211752 |
| 27 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.80679297 |
| 28 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.79791224 |
| 29 | Steatorrhea (HP:0002570) | 2.76895853 |
| 30 | Gingival bleeding (HP:0000225) | 2.70679218 |
| 31 | Vascular calcification (HP:0004934) | 2.58694358 |
| 32 | Mitral stenosis (HP:0001718) | 2.56659516 |
| 33 | Hyperammonemia (HP:0001987) | 2.45720395 |
| 34 | Hypercholesterolemia (HP:0003124) | 2.41689543 |
| 35 | Pulmonary embolism (HP:0002204) | 2.41147314 |
| 36 | Rickets (HP:0002748) | 2.38109779 |
| 37 | Myocardial infarction (HP:0001658) | 2.28140807 |
| 38 | Cardiovascular calcification (HP:0011915) | 2.27974508 |
| 39 | Thrombophlebitis (HP:0004418) | 2.26520234 |
| 40 | Eczematoid dermatitis (HP:0000976) | 2.23414555 |
| 41 | Polygenic inheritance (HP:0010982) | 2.22730597 |
| 42 | Spontaneous abortion (HP:0005268) | 2.20536742 |
| 43 | Hypoalphalipoproteinemia (HP:0003233) | 2.20240750 |
| 44 | Cerebral palsy (HP:0100021) | 2.19880043 |
| 45 | Abnormality of nucleobase metabolism (HP:0010932) | 2.19652161 |
| 46 | Abnormality of the intrinsic pathway (HP:0010989) | 2.09570367 |
| 47 | Polycythemia (HP:0001901) | 2.09546694 |
| 48 | Abnormality of the nasal mucosa (HP:0000433) | 2.07983948 |
| 49 | Joint swelling (HP:0001386) | 2.06117267 |
| 50 | Hyperglycinuria (HP:0003108) | 2.05408850 |
| 51 | Ileus (HP:0002595) | 1.99573539 |
| 52 | Focal segmental glomerulosclerosis (HP:0000097) | 1.97565011 |
| 53 | Abnormality of the Achilles tendon (HP:0005109) | 1.97238750 |
| 54 | Gangrene (HP:0100758) | 1.97182788 |
| 55 | Abnormality of glycine metabolism (HP:0010895) | 1.96348997 |
| 56 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.96348997 |
| 57 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.95791936 |
| 58 | Villous atrophy (HP:0011473) | 1.95791936 |
| 59 | Increased IgE level (HP:0003212) | 1.91356868 |
| 60 | Gastrointestinal stroma tumor (HP:0100723) | 1.91252890 |
| 61 | Colitis (HP:0002583) | 1.90962040 |
| 62 | Hypophosphatemia (HP:0002148) | 1.89285423 |
| 63 | Emphysema (HP:0002097) | 1.88875499 |
| 64 | Delayed CNS myelination (HP:0002188) | 1.86237591 |
| 65 | Epistaxis (HP:0000421) | 1.86173087 |
| 66 | Elevated alkaline phosphatase (HP:0003155) | 1.84409440 |
| 67 | Hepatocellular carcinoma (HP:0001402) | 1.81628906 |
| 68 | Periodontitis (HP:0000704) | 1.79889822 |
| 69 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.79794079 |
| 70 | Mucopolysacchariduria (HP:0008155) | 1.79794079 |
| 71 | Amyloidosis (HP:0011034) | 1.79359561 |
| 72 | Chronic otitis media (HP:0000389) | 1.78296496 |
| 73 | Alkalosis (HP:0001948) | 1.77897157 |
| 74 | Vasculitis (HP:0002633) | 1.76899360 |
| 75 | Hypochromic anemia (HP:0001931) | 1.75334264 |
| 76 | Abnormality of vitamin metabolism (HP:0100508) | 1.75212023 |
| 77 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.73541947 |
| 78 | Skin rash (HP:0000988) | 1.73467984 |
| 79 | Increased serum ferritin (HP:0003281) | 1.73051031 |
| 80 | Bone pain (HP:0002653) | 1.72469568 |
| 81 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.71363701 |
| 82 | Gingivitis (HP:0000230) | 1.71147273 |
| 83 | Abnormal gallbladder physiology (HP:0012438) | 1.70969495 |
| 84 | Cholecystitis (HP:0001082) | 1.70969495 |
| 85 | Pancreatitis (HP:0001733) | 1.70662838 |
| 86 | Gout (HP:0001997) | 1.70524035 |
| 87 | Generalized aminoaciduria (HP:0002909) | 1.69542648 |
| 88 | Nasal polyposis (HP:0100582) | 1.69484234 |
| 89 | Epidermoid cyst (HP:0200040) | 1.69279277 |
| 90 | Orchitis (HP:0100796) | 1.66436679 |
| 91 | Recurrent bronchitis (HP:0002837) | 1.65818916 |
| 92 | Stroke (HP:0001297) | 1.65750595 |
| 93 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.63631202 |
| 94 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.63631202 |
| 95 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.63631202 |
| 96 | Glomerulosclerosis (HP:0000096) | 1.61564347 |
| 97 | Abdominal distention (HP:0003270) | 1.60262689 |
| 98 | Acne (HP:0001061) | 1.59862880 |
| 99 | Pulmonary infiltrates (HP:0002113) | 1.59732482 |
| 100 | Late onset (HP:0003584) | 1.56846005 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.52451476 |
| 2 | FGFR4 | 4.99115910 |
| 3 | RIPK1 | 4.46867782 |
| 4 | MST1R | 4.13165864 |
| 5 | TYK2 | 3.55956986 |
| 6 | SMG1 | 2.85461512 |
| 7 | EPHA3 | 2.77614549 |
| 8 | FGFR3 | 2.49792878 |
| 9 | TRIB3 | 2.41988857 |
| 10 | MAP4K1 | 2.15143737 |
| 11 | TBK1 | 2.14662255 |
| 12 | EPHA2 | 2.13765391 |
| 13 | PRPF4B | 2.04082874 |
| 14 | JAK1 | 2.02555076 |
| 15 | EPHB1 | 1.85544537 |
| 16 | IRAK3 | 1.82647301 |
| 17 | IKBKE | 1.73522956 |
| 18 | MAP3K14 | 1.72488032 |
| 19 | CDC42BPA | 1.58380761 |
| 20 | JAK3 | 1.48971435 |
| 21 | MET | 1.41937852 |
| 22 | PTK6 | 1.30505838 |
| 23 | MAP3K3 | 1.27947869 |
| 24 | SIK1 | 1.16229545 |
| 25 | KIT | 1.15450946 |
| 26 | ZAP70 | 1.13890280 |
| 27 | TGFBR2 | 1.13320540 |
| 28 | EPHB2 | 1.11285513 |
| 29 | MAP3K1 | 1.10761493 |
| 30 | FER | 1.05319380 |
| 31 | PDK2 | 1.02521994 |
| 32 | DDR2 | 0.99914958 |
| 33 | ICK | 0.99220608 |
| 34 | PDGFRA | 0.98883787 |
| 35 | MAPK11 | 0.98105638 |
| 36 | MATK | 0.97749517 |
| 37 | IRAK1 | 0.95287382 |
| 38 | BLK | 0.93095408 |
| 39 | KDR | 0.91928688 |
| 40 | HIPK2 | 0.89910721 |
| 41 | MAP3K11 | 0.89221619 |
| 42 | PRKG2 | 0.87580639 |
| 43 | NLK | 0.84945346 |
| 44 | CHUK | 0.80876138 |
| 45 | CSF1R | 0.80831223 |
| 46 | MAP3K10 | 0.80170045 |
| 47 | IKBKB | 0.79465049 |
| 48 | JAK2 | 0.78331111 |
| 49 | PIK3CA | 0.77861258 |
| 50 | PDPK1 | 0.74306895 |
| 51 | PKN2 | 0.74103558 |
| 52 | ACVR1B | 0.72597621 |
| 53 | TAOK1 | 0.72582180 |
| 54 | MAP3K2 | 0.72450768 |
| 55 | MAP3K13 | 0.72327599 |
| 56 | ERBB2 | 0.67338671 |
| 57 | MAPK7 | 0.67177306 |
| 58 | RET | 0.64072990 |
| 59 | MAP3K12 | 0.63535113 |
| 60 | MAPKAPK3 | 0.62440616 |
| 61 | LRRK2 | 0.61279252 |
| 62 | TIE1 | 0.59661778 |
| 63 | GRK6 | 0.58540070 |
| 64 | PRKAA2 | 0.51427653 |
| 65 | PRKACG | 0.50966214 |
| 66 | IGF1R | 0.46865782 |
| 67 | LCK | 0.46803005 |
| 68 | TESK2 | 0.45821601 |
| 69 | CSK | 0.45570738 |
| 70 | SRC | 0.43801199 |
| 71 | IRAK4 | 0.42124539 |
| 72 | MAP3K7 | 0.41938106 |
| 73 | PRKD2 | 0.41105007 |
| 74 | MAP2K2 | 0.40931475 |
| 75 | PDK1 | 0.40628178 |
| 76 | RIPK4 | 0.40286090 |
| 77 | PTK2 | 0.39917114 |
| 78 | DYRK1B | 0.39846415 |
| 79 | CDK12 | 0.38567207 |
| 80 | FES | 0.37990612 |
| 81 | CDK9 | 0.36830576 |
| 82 | MYLK | 0.36233511 |
| 83 | LYN | 0.35782303 |
| 84 | MAPKAPK2 | 0.35491842 |
| 85 | PAK4 | 0.32696813 |
| 86 | FYN | 0.32677295 |
| 87 | TESK1 | 0.32139688 |
| 88 | MTOR | 0.31871358 |
| 89 | MAP3K6 | 0.30647900 |
| 90 | PRKCZ | 0.29867010 |
| 91 | DMPK | 0.28786594 |
| 92 | DAPK1 | 0.27379641 |
| 93 | SIK2 | 0.26608581 |
| 94 | MAPK4 | 0.25696878 |
| 95 | MAPK3 | 0.25500951 |
| 96 | NME1 | 0.24954105 |
| 97 | NEK6 | 0.24743847 |
| 98 | SYK | 0.24195541 |
| 99 | ABL2 | 0.23536876 |
| 100 | SIK3 | 0.22752607 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.82667241 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.81556508 |
| 3 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.60437842 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.23246139 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.89079657 |
| 6 | Retinol metabolism_Homo sapiens_hsa00830 | 2.84157850 |
| 7 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.76741309 |
| 8 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.72983829 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.64697385 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.63205313 |
| 11 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.57547471 |
| 12 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.54549882 |
| 13 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.46974801 |
| 14 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.39484454 |
| 15 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.30540056 |
| 16 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.14495335 |
| 17 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.05887372 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 2.05207530 |
| 19 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.94996274 |
| 20 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.92207689 |
| 21 | Bile secretion_Homo sapiens_hsa04976 | 1.72932816 |
| 22 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.64179871 |
| 23 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.61830057 |
| 24 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.60022490 |
| 25 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.54838824 |
| 26 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.54661497 |
| 27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.52602521 |
| 28 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.32211608 |
| 29 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.31891629 |
| 30 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.25187081 |
| 31 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.12519314 |
| 32 | Asthma_Homo sapiens_hsa05310 | 1.12256237 |
| 33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.07882604 |
| 34 | Pertussis_Homo sapiens_hsa05133 | 1.07390352 |
| 35 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.04222379 |
| 36 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.02549711 |
| 37 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.01783502 |
| 38 | Other glycan degradation_Homo sapiens_hsa00511 | 1.00131137 |
| 39 | Allograft rejection_Homo sapiens_hsa05330 | 0.99032988 |
| 40 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.98373342 |
| 41 | Prion diseases_Homo sapiens_hsa05020 | 0.94820155 |
| 42 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.92507343 |
| 43 | Peroxisome_Homo sapiens_hsa04146 | 0.92239452 |
| 44 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.91444628 |
| 45 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.90252272 |
| 46 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.88258826 |
| 47 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.86593607 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 0.84384936 |
| 49 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.82173613 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.80779913 |
| 51 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.80283434 |
| 52 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.79292248 |
| 53 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.78214075 |
| 54 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.76370125 |
| 55 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.74762374 |
| 56 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.73353845 |
| 57 | Galactose metabolism_Homo sapiens_hsa00052 | 0.70920073 |
| 58 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.69210524 |
| 59 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68672058 |
| 60 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.68068952 |
| 61 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.66202640 |
| 62 | Carbon metabolism_Homo sapiens_hsa01200 | 0.63991420 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.62288209 |
| 64 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.62222596 |
| 65 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.59648453 |
| 66 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.59296651 |
| 67 | Leishmaniasis_Homo sapiens_hsa05140 | 0.58703070 |
| 68 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.55423570 |
| 69 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.51468066 |
| 70 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.50218141 |
| 71 | Hepatitis C_Homo sapiens_hsa05160 | 0.47041360 |
| 72 | Influenza A_Homo sapiens_hsa05164 | 0.44318270 |
| 73 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.39906015 |
| 74 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.38159466 |
| 75 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37229562 |
| 76 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.34934327 |
| 77 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.33989609 |
| 78 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.32456625 |
| 79 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.31795408 |
| 80 | Viral myocarditis_Homo sapiens_hsa05416 | 0.31750778 |
| 81 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.29233961 |
| 82 | Insulin resistance_Homo sapiens_hsa04931 | 0.29172458 |
| 83 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.27215902 |
| 84 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.26609324 |
| 85 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.24565369 |
| 86 | Mineral absorption_Homo sapiens_hsa04978 | 0.24550334 |
| 87 | Sulfur relay system_Homo sapiens_hsa04122 | 0.24172995 |
| 88 | Lysine degradation_Homo sapiens_hsa00310 | 0.23588354 |
| 89 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.22727798 |
| 90 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.19576068 |
| 91 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.19525296 |
| 92 | Metabolic pathways_Homo sapiens_hsa01100 | 0.18547945 |
| 93 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.17420081 |
| 94 | Tuberculosis_Homo sapiens_hsa05152 | 0.16790648 |
| 95 | Amoebiasis_Homo sapiens_hsa05146 | 0.15755337 |
| 96 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.15036423 |
| 97 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.14422058 |
| 98 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.13718323 |
| 99 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.13033776 |
| 100 | Lysosome_Homo sapiens_hsa04142 | 0.09939762 |

